China Nuokang Bio-Pharmaceutical Inc. Announces Completion of Merger
February 07, 2013 04:54 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Feb. 7, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary General Meeting of Shareholders
January 29, 2013 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Jan. 29, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it will reconvene the extraordinary general meeting of...
China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General Meeting of Shareholders
January 15, 2013 04:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Jan. 15, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it has adjourned its extraordinary general meeting of...
China Nuokang Bio-Pharmaceutical Inc. Proposes to Adjourn Extraordinary General Meeting of Shareholders
January 14, 2013 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Jan. 14, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it intends to adjourn its extraordinary general meeting...
China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General Meeting of Shareholders
December 14, 2012 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Dec. 14, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial Results
November 25, 2012 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
3Q12 Revenue was RMB75.4 Million ($12.0 Million)
3Q12 Net Income was RMB2.5 Million ($0.4 Million)
3Q12 Non-GAAP Adjusted Net Income was RMB11.6 Million ($1.8 Million)
Live conference call to...
China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial Results
November 05, 2012 08:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Nov. 5, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private Transaction
September 27, 2012 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Sept. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports Second Quarter 2012 Financial Results
August 22, 2012 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
2Q12 Revenue was RMB72.9 Million ($11.5 Million)
2Q12 Net Income was RMB10.5 Million ($1.7 Million)
2Q12 Non-GAAP Adjusted Net Income was RMB11.3 Million ($1.8 Million)
Live conference call to...
China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2012 Financial Results
August 01, 2012 08:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Aug. 1, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...